vs

Side-by-side financial comparison of Aris Mining Corp (ARMN) and PULSE BIOSCIENCES, INC. (PLSE). Click either name above to swap in a different company.

PULSE BIOSCIENCES, INC. is the larger business by last-quarter revenue ($264.0K vs $151.1K, roughly 1.7× Aris Mining Corp). Aris Mining Corp runs the higher net margin — 13.6% vs -6603.4%, a 6617.0% gap on every dollar of revenue.

Endeavour Mining plc is a multinational mining company that owns and operates gold mines in Côte d'Ivoire, Burkina Faso and Senegal. The company is headquartered in London, England, and is listed on the London Stock Exchange. It is a constituent of the FTSE 100 Index.

Colossal Biosciences Inc. is an American biotechnology and genetic engineering company working to de-extinct several extinct animals, including the woolly mammoth, the Tasmanian tiger, the northern white rhinoceros, the dire wolf, the dodo, and the moa. In 2023, it stated that it wants to have woolly mammoth hybrid calves by 2028, and wants to reintroduce them to the Arctic tundra habitat. Likewise, it launched the Tasmanian Thylacine Advisory Committee, a thylacine research project to releas...

ARMN vs PLSE — Head-to-Head

Bigger by revenue
PLSE
PLSE
1.7× larger
PLSE
$264.0K
$151.1K
ARMN
Higher net margin
ARMN
ARMN
6617.0% more per $
ARMN
13.6%
-6603.4%
PLSE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARMN
ARMN
PLSE
PLSE
Revenue
$151.1K
$264.0K
Net Profit
$20.5K
$-17.4M
Gross Margin
44.9%
Operating Margin
30.0%
-6914.0%
Net Margin
13.6%
-6603.4%
Revenue YoY
Net Profit YoY
10.1%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARMN
ARMN
PLSE
PLSE
Q4 25
$151.1K
$264.0K
Q3 25
$86.0K
Q2 25
$0
Q1 25
$0
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$0
Net Profit
ARMN
ARMN
PLSE
PLSE
Q4 25
$20.5K
$-17.4M
Q3 25
$-19.4M
Q2 25
$-19.2M
Q1 25
$-16.8M
Q4 24
$-19.4M
Q3 24
$-12.7M
Q2 24
$-11.4M
Q1 24
$-10.1M
Gross Margin
ARMN
ARMN
PLSE
PLSE
Q4 25
44.9%
Q3 25
-224.4%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
ARMN
ARMN
PLSE
PLSE
Q4 25
30.0%
-6914.0%
Q3 25
-23682.6%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Net Margin
ARMN
ARMN
PLSE
PLSE
Q4 25
13.6%
-6603.4%
Q3 25
-22540.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
EPS (diluted)
ARMN
ARMN
PLSE
PLSE
Q4 25
$0.02
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARMN
ARMN
PLSE
PLSE
Cash + ST InvestmentsLiquidity on hand
$80.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$80.7M
Total Assets
$94.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARMN
ARMN
PLSE
PLSE
Q4 25
$80.7M
Q3 25
$95.2M
Q2 25
$106.3M
Q1 25
$119.3M
Q4 24
$118.0M
Q3 24
$79.0M
Q2 24
$26.2M
Q1 24
$34.9M
Stockholders' Equity
ARMN
ARMN
PLSE
PLSE
Q4 25
$80.7M
Q3 25
$92.7M
Q2 25
$104.5M
Q1 25
$118.5M
Q4 24
$114.9M
Q3 24
$79.1M
Q2 24
$27.0M
Q1 24
$36.3M
Total Assets
ARMN
ARMN
PLSE
PLSE
Q4 25
$94.5M
Q3 25
$108.8M
Q2 25
$120.3M
Q1 25
$133.4M
Q4 24
$132.5M
Q3 24
$93.0M
Q2 24
$40.4M
Q1 24
$49.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARMN
ARMN
PLSE
PLSE
Operating Cash FlowLast quarter
$99.1K
$-14.8M
Free Cash FlowOCF − Capex
$-14.9M
FCF MarginFCF / Revenue
-5628.8%
Capex IntensityCapex / Revenue
39.8%
Cash ConversionOCF / Net Profit
4.82×
TTM Free Cash FlowTrailing 4 quarters
$-54.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARMN
ARMN
PLSE
PLSE
Q4 25
$99.1K
$-14.8M
Q3 25
$-13.0M
Q2 25
$-12.8M
Q1 25
$-13.5M
Q4 24
$-9.1M
Q3 24
$-9.0M
Q2 24
$-8.4M
Q1 24
$-9.8M
Free Cash Flow
ARMN
ARMN
PLSE
PLSE
Q4 25
$-14.9M
Q3 25
$-13.1M
Q2 25
$-12.9M
Q1 25
$-13.6M
Q4 24
$-9.2M
Q3 24
$-9.1M
Q2 24
$-8.4M
Q1 24
$-9.8M
FCF Margin
ARMN
ARMN
PLSE
PLSE
Q4 25
-5628.8%
Q3 25
-15233.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
ARMN
ARMN
PLSE
PLSE
Q4 25
39.8%
Q3 25
72.1%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
ARMN
ARMN
PLSE
PLSE
Q4 25
4.82×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons